ASC linear deubiquitination by Spata2-CYLD inhibits NLRP3 inflammasome activation

ASC linear deubiquitination by Spata2-CYLD inhibits NLRP3 inflammasome activation

WU Dan-dan, JIANG Xiao-li, ZHANG Shuang-yan, et al

PDF(821 KB)

Welcome to Current Immunology, Today is

PDF(821 KB)

Current Immunology ›› 2021, Vol. 41 ›› Issue (4) : 272-277.

ASC linear deubiquitination by Spata2-CYLD inhibits NLRP3 inflammasome activation

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 41(4): 272-277

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(821 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉